Paul Wisman
Pediatrics · Charlottesville, VANPI 1235115650
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,365 of the $10,192 with a category attached, or 82.1%. 10 manufacturers reported payments, led by Gilead at 42.2% of the total. 2025 is the largest year on record at $4,617, 3.6 times the $1,296 reported in 2019. Among pediatrics clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 28 payments — averaging $363.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$4K
- Sanofi Pasteur Inc.$4K
- Seqirus USA Inc$1K
- Supernus Pharmaceuticals, Inc.$147
- Merck$146
- ARS Pharmaceuticals Operations, Inc.$138
- plus $100 from 4 others
Across 680 payments — averaging $8247.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3.7M
- Sanofi Pasteur Inc.$615K
- Merck$405K
- Roche Molecular Systems, Inc.$267K
- AstraZeneca$174K
- Seqirus USA Inc$120K
- plus $345K from 9 others
What the payments were for
- Consulting fees$8,36582%
- Travel & lodging$1,01610%
- Food & beverage$8108%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 1 | $4,300 |
| Sanofi Pasteur Inc. | 2 | $4,065 |
| Seqirus USA Inc | 6 | $1,296 |
| Supernus Pharmaceuticals, Inc. | 7 | $147 |
| Merck | 6 | $146 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $49 |
| Kaleo, Inc. | 1 | $18 |
| Sobi, Inc | 1 | $18 |
| GSK | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PENTACEL$1,355
- FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)$1,236
- NEFFY$111
How this compares
$10,192 in reported general payments places this provider in the 95th percentile of 1,542 pediatrics providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine | 13 | $358 |
| Tamsulosin Hcl | 14 | $291 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Charlottesville
- Alan RogolCharlottesville$142K
- Christina PeroutkaCharlottesville$16K
- Patricia MulreanyMidlothian$1.5M
- Dominick PastoreRichmond$1.1M
- Judith GrossbergMidlothian$291K
- Elizabeth CullenMidlothian$289K
- Martha SaundersMidlothian$288K
- Anne Marie IraniRichmond$265K
- Ozlem Goker-AlpanFairfax$210K
- Tamara SutherlandGlen Allen$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.